SML3271
Sinonimo/i:
5-Chloro-3-[4-(methylsulfonyl)phenyl]-2-(2-methyl-5-pyridinyl)pyridine, 5-Chloro-6′-methyl-3-[4-(methylsulfonyl)phenyl]-2,3′-bipyridine
Proprietà
Etoricoxib, ≥95% (HPLC)
100
≥95% (HPLC)
powder
white to beige
DMSO: 2 mg/mL, clear
2-8°C
CC1=NC=C(C2=C(C3=CC=C(S(C)(=O)=O)C=C3)C=C(Cl)C=N2)C=C1
1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3
MNJVRJDLRVPLFE-UHFFFAOYSA-N
Descrizione
Mostra le differenze
1 of 1
Sigma-Aldrich
Etoricoxib
Supelco
32097
SML2705
TP-008
SML3379
D159687
VETRANAL®, analytical standard
≥98% (HPLC)
-
DMSO: 2 mg/mL, clear (Warmed)
Explore all of our products under Etoricoxib
Danger
Acute Tox. 2 Dermal - Acute Tox. 4 Oral
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
WGK 3
Scegli una delle versioni più recenti:
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.
Se ti serve aiuto, non esitare a contattarci Servizio Clienti
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Visita l’Archivio dei documenti
Categorie correlate
Bioactive Small Molecule Agonists
Bioactive Small Molecules